Galapagos NV
GLPG
#4874
Rank
โ‚น181.24 B
Marketcap
โ‚น2,699
Share price
-0.14%
Change (1 day)
24.13%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2025 (TTM): -โ‚น34.67

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is -โ‚น31.95. In 2024 the company made an earnings per share (EPS) of โ‚น109.82 a decrease over its 2023 EPS that were of โ‚น334.37.

EPS history for Galapagos NV from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น34.67-131.57%
2024โ‚น109.82-67.16%
2023โ‚น334.37-199.64%
2022-โ‚น335.5799.03%
2021-โ‚น168.61-68.98%
2020-โ‚น543.57-298.06%
2019โ‚น274.45-554.64%
2018-โ‚น60.37-77.18%
2017-โ‚น264.56-326.21%
2016โ‚น116.95-134.19%
2015-โ‚น342.06-371.34%
2014โ‚น126.06-445.98%
2013-โ‚น36.4432.88%
2012-โ‚น27.42-82.07%
2011-โ‚น152.96-817.9%
2010โ‚น21.3112.73%
2009โ‚น18.90-120.79%
2008-โ‚น90.89-37.67%
2007-โ‚น145.8439.64%
2006-โ‚น104.4428.17%
2005-โ‚น81.486.25%
2004-โ‚น76.69

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น1,050-3,384.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น353.38-1,205.90%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น225.35-805.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น194.60-708.98%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚น688.84-2,255.70%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น558.77-1,848.66%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น355.05-1,211.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
-โ‚น57.48 79.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น116.84-465.66%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel